Case number 1:18-cv-01074
Eagle Pharmaceuticals, Inc. et al v. Hospira, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 20, 2022 | 160 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,572,887 B2; US 10,010,533 B2; US 9,034,908 B2; US 9,144,568 B1; US 9,597,397 B2. (Attachments: # (1) Stipulation of Dismissal with prejudice)(kmd) |
| Apr 20, 2022 | 160 | Stipulation of Dismissal with prejudice (3) |
| Apr 19, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per [159] STIPULATION of Dismissal with prejudice. (kmd) |
| Apr 19, 2022 | 159 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal with prejudice by Eagle Pharmaceuticals, Inc.. (Silver, Daniel) |
| Apr 13, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before April 20, 2022, the parties shall jointly submit a glossary of terms and names for the court reporter. Ordered by Judge Colm F. Connolly on 4/13/2022. (nmf) |
| Apr 7, 2022 | 158 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel by Hospira, Inc. (Connolly, Arthur) |
| Mar 31, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel) |
| Mar 31, 2022 | 157 | Main Document (22) Docket Text: REDACTED VERSION of [156] Proposed Pretrial Order by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits 1-10)(Silver, Daniel) |
| Mar 31, 2022 | 157 | Exhibits 1-10 (787) |
| Mar 28, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has reviewed Hospira's March 24 letter and will grant Hospira's request to have Dr. Knill and Mr. Norris testify remotely at trial. Ordered by Judge Colm F. Connolly on 3/28/2022. (nmf) |
| Mar 24, 2022 | 155 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Arthur G. Connolly, III, Esq. regarding Remote Witnesses at Trial. (Connolly, Arthur) |
| Mar 18, 2022 | 154 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Notice Pursuant to 35 U.S.C. § 282 filed by Hospira, Inc..(Silverstein, Alan) |
| Mar 4, 2022 | 153 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Eagle Pharmaceuticals, Inc.: Entry of appearance of attorney Daniel M. Silver. Attorney John W. Shaw, Karen E. Keller, and Nathan Hoeschen terminated. (Silver, Daniel) |
| Feb 24, 2022 | 151 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Alan Richard Silverstein on behalf of Hospira, Inc. (Silverstein, Alan) |
| Feb 24, 2022 | 152 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Kelly M. Conlan on behalf of Hospira, Inc. (Conlan, Kelly) |
| Jan 13, 2022 | 150 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Bruce D. Cheson, M.D. filed by Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Oct 27, 2021 | 149 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER: Resetting Deadlines/Hearings: Proposed Pretrial Order due by 3/24/2022. Signed by Judge Colm F. Connolly on 10/27/2021. (kmd) |
| Oct 26, 2021 | 148 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to File Proposed Pretrial Order to March 24, 2022 - filed by Hospira, Inc.. (Connolly, Arthur) |
| Oct 14, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [147] Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding Status Report., Set/Reset Scheduling Order Deadlines: (The Final Pretrial Conference is rescheduled for 4/14/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly., The Bench Trial is rescheduled for 4/25/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 10/14/2021. (nmf) |
| Oct 13, 2021 | 147 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding Status Report. (Hoeschen, Nathan) |
| Oct 7, 2021 | 145 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file Daubert Motions Relating to Dr. Steven Coutre to Seven Days After Dr. Coutre's Deposition - filed by Hospira, Inc.. (Connolly, Arthur) |
| Oct 7, 2021 | 146 | SO ORDERED (2) Docket Text: SO ORDERED, re [145] STIPULATION TO EXTEND TIME to file Daubert Motions Relating to Dr. Steven Coutre to Seven Days After Dr. Coutre's Deposition filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 10/7/2021. (kmd) |
| Oct 5, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 10/5/2021. (Court Reporter V. Gunning.) (nmf) |
| Oct 4, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: A Telephonic Status Conference is set for 10/5/2021 at 10:00 AM before Judge Colm F. Connolly. Counsel to coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 10/4/2021. (nmf) |
| Sep 17, 2021 | 144 | SO ORDERED (3) Docket Text: SO ORDERED, re [143] MOTION for Extension of Time to File Daubert Motions (Unopposed) filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 9/17/2021. (nmf) |
| Sep 16, 2021 | 143 | Motion for Extension of Time (3) Docket Text: MOTION for Extension of Time to File Daubert Motions (Unopposed) - filed by Hospira, Inc.. (Connolly, Arthur) |
| Aug 13, 2021 | 142 | Notice (Other) (2) Docket Text: NOTICE of the Withdrawal of Brandon R. Harper as Counsel of Record by Hospira, Inc. (Connolly, Arthur) |
| Jul 30, 2021 | 141 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel by Hospira, Inc. (Connolly, Arthur) |
| Jul 28, 2021 | 139 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of Bernhardt Trout, Ph.D. (2) Reply Expert Report of Steven Edward Coutre, M.D. (3) Expert Report of Edmund J. Elder, Jr., Ph.D., R.Ph. filed by Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Jul 28, 2021 | 140 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of George M. Grass, Pharm.D, PhD, Reply Expert Report of Gavin W. Halbert, PhD, and Responsive Expert Report of Robert J. Soiffer, M.D. filed by Hospira, Inc..(Connolly, Arthur) |
| Jul 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [138] STIPULATION TO EXTEND TIME to Serve Reply Expert Reports to July 27, 2021 filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 7/20/2021. (fms) |
| Jul 19, 2021 | 138 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Serve Reply Expert Reports to July 27, 2021 - filed by Hospira, Inc.. (Connolly, Arthur) |
| Jul 9, 2021 | 137 | SO ORDERED (2) Docket Text: SO ORDERED, re [136] Proposed Order filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., ORDER, Setting Scheduling Order Deadlines ( Proposed Pretrial Order due by 11/1/2021.). Signed by Judge Colm F. Connolly on 7/9/2021. (nmf) |
| Jul 8, 2021 | 136 | Proposed Order (2) Docket Text: PROPOSED ORDER (Stipulation and Proposed Order re: Final Proposed Pretrial Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 21, 2021 | 134 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responsive Expert Report of Gavin W. Halbert, PhD filed by Hospira, Inc..(Connolly, Arthur) |
| Jun 21, 2021 | 135 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Responsive Expert Report of Dr. Zamboni (2) Responsive Expert Report of Dr. Leoni (3) Responsive Expert Report of Dr. Kittendorf (4) Responsive Expert Report of Dr. Trout (5) Responsive Expert Report of Dr. Coutre filed by Eagle Pharmaceuticals, Inc..(Keller, Karen) |
| Jun 10, 2021 | 133 | SO ORDERED (2) Docket Text: SO ORDERED, re [132] Joint STIPULATION TO EXTEND TIME to serve responsive expert reports and reply expert reports to June 18, 2021 and July 23, 2021 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 6/10/2021. (fms) |
| Jun 8, 2021 | 132 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to serve responsive expert reports and reply expert reports to June 18, 2021 and July 23, 2021 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 4, 2021 | 131 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Expert Report of Bernhardt Trout, Ph.D. 2) Expert Report of Steven Edward Coutre filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| May 3, 2021 | 129 | SO ORDERED (4) Docket Text: SO ORDERED, re [128] Stipulation filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 5/3/2021. (fms) |
| May 3, 2021 | 130 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Robert J. Soiffer, M.D., (2) Opening Expert Report of George M. Grass, Pharm.D., Ph.D., and (3) Opening Expert Report of Gavin W. Halbert, Ph.D. filed by Hospira, Inc..(Connolly, Arthur) |
| Apr 30, 2021 | 128 | Stipulation (4) Docket Text: Joint STIPULATION regarding Case Narrowing (and Proposed Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 6, 2021 | 127 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hospira, Inc.'s Third Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (No. 6) filed by Hospira, Inc..(Connolly, Arthur) |
| Apr 1, 2021 | 123 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Brandon Ryan Harper on behalf of Hospira, Inc. (Harper, Brandon) |
| Apr 1, 2021 | 124 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Stephanie S. Riley on behalf of Hospira, Inc. (Riley, Stephanie) |
| Apr 1, 2021 | 125 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Plaintiffs' Responses and Objections to Defendant's Second Set of Interrogatories (Nos. 10-15) 2. Plaintiff Eagle Pharmaceuticals, Inc.'s First Supplemental Response to Defendant's First Set of Interrogatories (Nos. 1-9) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Apr 1, 2021 | 126 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's First Supplemental Rule 26(A)(1) Initial Disclosures, (2) Hospira, Inc.'s First Supplemental Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 8-10), and (3) Hospira, Inc.'s Second Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-7) filed by Hospira, Inc..(Connolly, Arthur) |
| Mar 30, 2021 | 122 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Lauren K. Sharkey as co-counsel.. (Hoeschen, Nathan) |
| Mar 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [121] Stipulation filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 3/2/2021. (fms) |
| Mar 1, 2021 | 121 | Stipulation (2) Docket Text: STIPULATION to Extend Various Discovery Deadlines (and Proposed Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [120] MOTION for Pro Hac Vice Appearance of Attorney Lauren K. Sharkey filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/16/2021. (fms) |
| Feb 16, 2021 | 120 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lauren K. Sharkey - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Feb 11, 2021 | 119 | Main Document (2) Docket Text: NOTICE of Subpoena of Dr. Paul Bruinenberg by Hospira, Inc. (Attachments: # (1) Exhibit 1 - Subpoena)(Connolly, Arthur) |
| Feb 11, 2021 | 119 | Exhibit 1 - Subpoena (12) |
| Feb 3, 2021 | 118 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Eagle Pharmaceuticals' Responses and Objections to Hospira's Notice of 30(b)(6) Deposition (2) Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Responses and Objections to Hospira Inc.'s Notice of Deposition filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Feb 2, 2021 | 117 | Objections (22) Docket Text: OBJECTIONS by Hospira, Inc. to [112] Notice to Take Deposition . (Connolly, Arthur) |
| Jan 29, 2021 | 116 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.'s Second Set of Interrogatories to Plaintiffs Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International Gmbh, and Cephalon, Inc. (Nos. 10-15) filed by Hospira, Inc..(Connolly, Arthur) |
| Jan 22, 2021 | 113 | Notice (Other) (8) Docket Text: NOTICE of Rule 30(b)(6) Deposition of Plaintiff Eagle Pharmaceuticals, Inc. by Hospira, Inc. (Connolly, Arthur) |
| Jan 22, 2021 | 114 | Notice (Other) (8) Docket Text: NOTICE of Rule 30(b)(6) Deposition of Plaintiffs Cephalon, Inc. and Teva Pharmaceuticals International GmbH by Hospira, Inc. (Connolly, Arthur) |
| Jan 22, 2021 | 115 | Notice (Other) (6) Docket Text: NOTICE of Subpoena of Dr. Srikanth Sundaram by Hospira, Inc. (Connolly, Arthur) |
| Jan 20, 2021 | 112 | Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Hospira, Inc. on February 9, 2021 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jan 13, 2021 | 109 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Scott Tarriff on February 22, 2021 filed by Hospira, Inc..(Connolly, Arthur) |
| Jan 13, 2021 | 110 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Srikanth Sundaram on February 26, 2021 filed by Hospira, Inc..(Connolly, Arthur) |
| Jan 13, 2021 | 111 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Steven Krill on February 24, 2021 filed by Hospira, Inc..(Connolly, Arthur) |
| Dec 28, 2020 | 104 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Gary Brownlee on February 4, 2021 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 28, 2020 | 105 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Vanda Tedesco on February 9, 2021 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 28, 2020 | 106 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Andrew Knill on February 15, 2021 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 28, 2020 | 107 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Noel Norris on February 17, 2021 filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 28, 2020 | 108 | Order (2) Docket Text: CLAIM CONSTRUCTION ORDER re [103] Proposed Claim Construction Order. Signed by Judge Colm F. Connolly on 12/28/2020. (nmf) |
| Dec 22, 2020 | 103 | Proposed Order (2) Docket Text: PROPOSED ORDER ([Proposed] Claim Construction Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 18, 2020 | 102 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel by Hospira, Inc. (Connolly, Arthur) |
| Dec 15, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 12/15/2020. (Court Reporter V. Gunning.) (nmf) |
| Dec 14, 2020 | N/A | Remark (0) Docket Text: Remark: The 12/14/2020 Markman hearing is a public hearing. Having received a request from a member of the public to listen to the hearing, the call information is: Dial-In: 888-240-3210; Access Code: 8561978 (nmf) |
| Dec 14, 2020 | 101 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Arthur G. Connolly, III, Esq. regarding Request for Guidance on Highly Confidential Information Contained within Plaintiffs' Markman Presentation. (Connolly, Arthur) |
| Dec 10, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-Setting Hearings: The Markman Hearing is rescheduled as a Telephonic Markman Hearing on 12/15/2020 at 09:00 AM before Judge Colm F. Connolly. Counsel for the Plaintiffs shall coordinate the call and email the dial-in information to chambers. The parties shall email any slides they would like to present no later than 24 hours in advance of the hearing. Ordered by Judge Colm F. Connolly on 12/10/2020. (nmf) |
| Nov 3, 2020 | 99 | Redacted Document (30) Docket Text: REDACTED VERSION of [96] Joint Claim Construction Brief by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Nov 3, 2020 | 100 | Redacted Document (30) Docket Text: REDACTED VERSION of [97] Appendix by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 27, 2020 | 98 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding expert testimony at the claim construction hearing. (Hoeschen, Nathan) |
| Oct 2, 2020 | 95 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hospira's Supplemental Responses & Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) filed by Hospira, Inc..(Connolly, Arthur) |
| Sep 8, 2020 | 94 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendant's First Set of Interrogatories (Nos. 1-9) (2) Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendant's Second Set of Requests for the Production of Documents and Things (Nos. 72-83) (3) Teva Pharmaceuticals International GmbH And Cephalon, Inc.'s Responses and Objections to Hospira Inc.s Second Set of Requests for the Production of Documents and Things (Nos. 72-83) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Aug 5, 2020 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [93] MOTION for Claim Construction , [92] MOTION for Claim Construction (fms) |
| Aug 5, 2020 | 91 | Main Document (49) Docket Text: CLAIM Construction Chart by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Exhibit A: Patent No. '887)(Hoeschen, Nathan) |
| Aug 5, 2020 | 91 | Exhibit A: Patent No. '887 (19) |
| Aug 5, 2020 | 92 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) Modified on 8/6/2020 (fms). |
| Aug 5, 2020 | 93 | Motion for Miscellaneous Relief (1) Docket Text: MOTION for Claim Construction - filed by Hospira, Inc.. (Connolly, Arthur) Modified on 8/6/2020 (fms). |
| Aug 4, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [90] STIPULATION TO EXTEND TIME to submit a Joint Claim Chart to August 5, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 8/4/2020. (fms) |
| Aug 3, 2020 | 90 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a Joint Claim Chart to August 5, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jul 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [89] STIPULATION TO EXTEND TIME (and proposed order) to submit a joint claim chart to August 3, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 7/28/2020. (fms) |
| Jul 28, 2020 | 89 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit a joint claim chart to August 3, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Jul 27, 2020 | 88 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of the Appearance of Ryan P. Newell as Counsel for Defendant Hospira, Inc by Hospira, Inc. (Newell, Ryan) |
| Jul 24, 2020 | 87 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's First Set of Interrogatories to Plaintiffs Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH, and Cephalon, Inc. (Nos. 1-9) and (2) Defendant's Second Set of Requests for the Production of Documents and Things (Nos. 72-83) filed by Hospira, Inc..(Connolly, Arthur) |
| Jul 10, 2020 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents (Nos. 106-114) and Defendant's Responses to Plaintiffs' Second Set of Interrogatories (Nos. 8-10) filed by Hospira, Inc..(Connolly, Arthur) |
| Jun 11, 2020 | 85 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs Second Set of Interrogatories to Defendant Hospira, Inc. and 2) Plaintiffs Second Set of Requests for Production of Documents to Defendant Hospira, Inc. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| May 29, 2020 | 84 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Invalidity Contentions filed by Hospira, Inc..(Connolly, Arthur) |
| Apr 29, 2020 | 83 | Protective Order (26) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 4/29/2020. (fms) |
| Apr 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [81] Stipulation filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 4/28/2020. (fms) |
| Apr 28, 2020 | N/A | Deficiency Notice (0) Docket Text: DEFICIENCY NOTICE by the Court issued re [80] Proposed Protective Order. The proposed protective order does not contain the required Other Proceedings language found on page 9 of D.I. [44] Scheduling Order. (fms) |
| Apr 28, 2020 | 82 | Proposed Order (25) Docket Text: PROPOSED ORDER (Protective Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 27, 2020 | 81 | Stipulation (2) Docket Text: STIPULATION to Extend the Time for Defendant Hospira, Inc. to Submit its Invalidity Contentions by Hospira, Inc.. (Connolly, Arthur) |
| Apr 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [77] MOTION for Pro Hac Vice Appearance of Attorney Michael W. Johnson filed by Hospira, Inc., [76] MOTION for Pro Hac Vice Appearance of Attorney Ren-How Harn filed by Hospira, Inc. Signed by Judge Colm F. Connolly on 4/21/2020. (fms) |
| Apr 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [79] STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to April 21, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 4/21/2020. (fms) |
| Apr 21, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ren-How Harn for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Apr 21, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael W. Johnson for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Apr 21, 2020 | 80 | Proposed Order (24) Docket Text: PROPOSED ORDER (Protective Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 20, 2020 | 76 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ren-How Harn - filed by Hospira, Inc.. (Connolly, Arthur) |
| Apr 20, 2020 | 77 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael W. Johnson - filed by Hospira, Inc.. (Connolly, Arthur) |
| Apr 20, 2020 | 78 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur) |
| Apr 20, 2020 | 79 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to April 21, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [75] Joint STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 20, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 4/15/2020. (fms) |
| Apr 15, 2020 | 75 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 20, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 14, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [74] STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 15, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 4/14/2020. (fms) |
| Apr 13, 2020 | 74 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to April 15, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 7, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the parties' protective order dispute motion, (D.I. [61]), and the parties' letter briefs relating thereto, (D.I. 63; D.I. 64; D.I. 66; D.I. 67; D.I. 70; D.I. 72), and having heard argument on March 16, 2020, hereby ORDERS as follows with regard to the dispute: (1) With regard to the disputed language in paragraph 5(b) of the proposed protective order, the Court ADOPTS Defendant Hospira, Inc.'s ("Hospira") proposed language as modified in its March 24, 2020 supplemental letter, (D.I. 70 at 1-2). In considering the parties' dispute with respect to whether Hospira's two in-house counsel (Anne Christopher and Leah Taylor) should have access to Highly Confidential Information, the Court applies the familiar legal standard for such disputes set out in cases like Evertz Microsystems Ltd. v. Lawo Inc., C.A. No. 19-302-MN-JLH, 2019 WL 5864173, at *2-3 (D. Del. Nov. 8, 2019). Plaintiffs have identified particular areas of concern with regard to inadvertent disclosure in the initial round of briefing and during the telephonic argument. (See, e.g., D.I. 67 at 2; March 16, 2020 Transcript at 5-6) Hospira's proposed language is tailored to address those concerns, (see D.I. 70 at 1; March 16, 2020 Transcript at 23-24), and Ms. Christopher and Ms. Taylor have submitted Declarations in which they state that they are not involved in competitive decision-making with respect to those areas of concern, (D.I. 70, exs. 1-2 at paragraph 6). Plaintiffs' latest letter followed Ms. Christopher and Ms. Taylor's submission of their declarations outlining their roles in relation to Hospira and this case, yet it did not raise any additional specific concerns regarding inadvertent disclosure. (See D.I. 72) And as for Hospira's need for these two in-house counsel to have access to Plaintiffs' Highly Confidential Information, Ms. Christopher and Ms. Taylor provide detailed explanations in their Declarations with regard to their roles as critical parts of the litigation team, the significant length of time they have been working on patent issues relating to the liquid bendamustine product at issue, and how the inability to see such Highly Confidential Information would amount to a hardship. (D.I. 70, exs. 1-2) They also explain in detail how the status of Hospiras product and FDA approval of that product, their roles with respect to this case and as officers of the court, and their prior experience as attorneys who have been bound by the terms of similar protective orders before, all would mitigate against inadvertent disclosure of Plaintiffs' Highly Confidential Information. (Id.) In view of the record before the Court, the Court agrees with Hospira that the need for these in-house counsel to have access to Highly Confidential Information outweighs the minimal risk of inadvertent disclosure.; (2) The Court agrees with Plaintiffs, however, that Hospira should be held to its offer to keep the entirety of Plaintiffs' NDA on an outside-counsel-only basis, (see D.I. 70 at 2 n.1), for the reasons discussed by Plaintiffs, (D.I. 72 at 2 n.1).; and (3) By no later than April 13, 2020, the parties shall submit a proposed protective order reflecting the rulings herein. Ordered by Judge Christopher J. Burke on 4/7/2020. (mlc) |
| Mar 31, 2020 | 72 | Letter (4) Docket Text: Letter to The Honorable Christopher J. Burke from Nathan R. Hoeschen regarding protective order dispute. (Hoeschen, Nathan) |
| Mar 30, 2020 | 71 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva Pharmaceuticals International GmbH And Cephalon, Inc.'s Responses and Objections to Hospira Inc.'s First Set of Requests for the Production of Documents and Things (Nos. 1-71) (2) Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendant's First Set of Requests for the Production of Documents and Things (Nos. 1-71) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 24, 2020 | 70 | Main Document (2) Docket Text: Letter to The Honorable Christopher J. Burke from Arthur G. Connolly, III regarding supplement to the record regarding Protective Order dispute - re [68] Oral Order,,,,,. (Attachments: # (1) Declaration of Anne Elizabeth Christopher, # (2) Declaration of Leah Victoria Taylor)(Connolly, Arthur) |
| Mar 24, 2020 | 70 | Declaration of Anne Elizabeth Christopher (7) |
| Mar 24, 2020 | 70 | Declaration of Leah Victoria Taylor (7) |
| Mar 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [69] STIPULATION TO EXTEND TIME Regarding Protective Order Dispute: Time for Defendant to Supplement Record and for Plaintiffs to Respond to March 24, 2020 and March 31, 2020 respectively. filed by Hospira, Inc.. Ordered by Judge Christopher J. Burke on 3/18/2020. (dlb) |
| Mar 18, 2020 | 69 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Regarding Protective Order Dispute: Time for Defendant to Supplement Record and for Plaintiffs to Respond to March 24, 2020 and March 31, 2020 respectively. - filed by Hospira, Inc.. (Connolly, Arthur) |
| Mar 16, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Christopher J. Burke - Protective order dispute teleconference held on 3/16/2020. The Court heard argument regarding the parties' protective order dispute, (D.I. 61), and took the matter under advisement. (Court Reporter Valerie Gunning. Clerk: M. Crawford) Appearances: N. Hoeschen, A. Grabowski, M. Zubick for Plaintiff Eagle Pharmaceuticals, Inc.; A. Harber, B. Picozzi for Plaintiff Teva Pharmaceuticals International GmbH; A. Connolly, S. Horton, A. Barlow for Defendant. (mlc) |
| Mar 16, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, in line with its discussion with the parties on today's teleconference regarding the protective order dispute, (D.I. 61), HEREBY ORDERS as follows: (1) By no later than March 19, 2020, Defendant may further supplement the record by filing a letter (with attachments, such as affidavits/declarations, if necessary) of no more than 2 single-spaced pages which: (a) provides additional information regarding the two in-house counsel ("counsel") that Defendant proposes have access to Plaintiffs' highly confidential information under the protective order, including, for example, counsel's job duties relating to the product at issue in this litigation, the extent to which counsel engages in competitive decision-making, and the potential harm to Defendant would counsel be denied access to such information; and (b) sets out the language of any revised proposal from Defendant regarding the disputed protective order provision at issue.; and (2) By no later than March 24, 2020, Plaintiffs may file a responsive letter (with attachments, if necessary) of no more than 2 single-spaced pages that addresses the arguments and/or any revised proposal made by Defendant. Ordered by Judge Christopher J. Burke on 3/16/2020. (dlb) |
| Mar 11, 2020 | 65 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH, and Cephalon, Inc.'s Initial Infringement Contentions filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 11, 2020 | 66 | Letter (2) Docket Text: Letter to The Honorable Christopher J. Burke from Arthur G. Connolly, III regarding Responding to Plaintiffs' March 5, 2020 Letter Regarding Protective Order Dispute - re [64] Letter. (Connolly, Arthur) |
| Mar 11, 2020 | 67 | Main Document (4) Docket Text: Letter to The Honorable Christopher J. Burke from Nathan R. Hoeschen regarding protective order dispute - re [63] Letter. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E)(Hoeschen, Nathan) |
| Mar 11, 2020 | 67 | Exhibit A (22) |
| Mar 11, 2020 | 67 | Exhibit B (33) |
| Mar 11, 2020 | 67 | Exhibit C (21) |
| Mar 11, 2020 | 67 | Exhibit D (32) |
| Mar 11, 2020 | 67 | Exhibit E (6) |
| Mar 5, 2020 | 63 | Main Document (2) Docket Text: Letter to Magistrate Judge Christopher J. Burke from Arthur G. Connolly, III regarding Protective Order Dispute. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Connolly, Arthur) |
| Mar 5, 2020 | 63 | Exhibit A (25) |
| Mar 5, 2020 | 63 | Exhibit B (8) |
| Mar 5, 2020 | 64 | Main Document (5) Docket Text: Letter to The Honorable Christopher J. Burke from Nathan R. Hoeschen regarding Protective Order Dispute. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Hoeschen, Nathan) |
| Mar 5, 2020 | 64 | Exhibit A (9) |
| Mar 5, 2020 | 64 | Exhibit B (25) |
| Mar 2, 2020 | 61 | Main Document (1) Docket Text: Joint MOTION for Teleconference to Resolve Protective Order Dispute - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Joint Letter Regarding Protective Order Dispute)Motions referred to Christopher J. Burke.(Hoeschen, Nathan) |
| Mar 2, 2020 | 61 | Joint Letter Regarding Protective Order Dispute (2) |
| Mar 2, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER setting protective order dispute teleconference: The Court, having reviewed the parties' joint letter regarding a protective order dispute, (D.I. 61, ex. 1), hereby ORDERS that the procedures for resolving a protective order dispute set out in paragraph 12 of the Scheduling Order, (D.I. 44), shall be modified as follows: (1) A protective order dispute teleconference will be held on March 16, 2020 at 2:00 PM before Judge Christopher J. Burke; (2) By March 5, 2020, each party shall file with the Court a letter, not to exceed two (2) pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues, including the party's proposal as to how the content of the disputed portion(s) of the protective order should read. By March 11, 2020, each party may file a letter, not to exceed two (2) pages, in no less than 12-point font, outlining that party's response to the opposing party's initial letter.; (3) Two courtesy copies of the letters are to be hand delivered to the Clerk's Office within one hour of e-filing.; and (4) The Court may choose to resolve the dispute on the papers prior to the teleconference. If it does so, it will thereafter cancel the teleconference. Ordered by Judge Christopher J. Burke on 3/2/2020. (dlb) |
| Feb 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [60] STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to March 2, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/28/2020. (fms) |
| Feb 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [59] STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to February 27, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/27/2020. (nmf) |
| Feb 27, 2020 | 60 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to March 2, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 26, 2020 | 59 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to February 27, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [55] STIPULATION TO EXTEND TIME for plaintiffs to serve their Disclosure of Asserted Claims and Infringement Contentions and accompanying document production and defendant to serve its Invalidity Contentions and accompanying document production to March 11 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/24/2020. (nmf) |
| Feb 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [56] STIPULATION TO EXTEND TIME to submit a proposed protective order to February 26, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/24/2020. (nmf) |
| Feb 24, 2020 | 55 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for plaintiffs to serve their Disclosure of Asserted Claims and Infringement Contentions and accompanying document production and defendant to serve its Invalidity Contentions and accompanying document production to March 11, 2020 and April 28, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 24, 2020 | 56 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to February 26, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 24, 2020 | 57 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hospira, Inc.'s Initial Paragraph 3 Disclosures filed by Hospira, Inc..(Connolly, Arthur) |
| Feb 24, 2020 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery 2) Plaintiff Eagle Pharmaceuticals, Inc.s Initial Disclosures Pursuant to Delaware Default Standard for Discovery filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Feb 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [54] STIPULATION TO EXTEND TIME submit proposed protective order to February 24, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/18/2020. (fms) |
| Feb 17, 2020 | 54 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME submit proposed protective order to February 24, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 14, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sara Tonnies Horton for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Feb 14, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Yusuf Esat for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Feb 14, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Aaron A. Barlow for Hospira, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Feb 13, 2020 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc.'s First Set of Requests for the Production of Documents and Things (Nos. 1-71) filed by Hospira, Inc..(Newell, Ryan) |
| Feb 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [52] STIPULATION TO EXTEND TIME to submit a proposed protective order to February 17, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/10/2020. (nmf) |
| Feb 7, 2020 | 52 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to February 17, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Feb 6, 2020 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by Eagle Pharmaceuticals, Inc..(Hoeschen, Nathan) |
| Feb 6, 2020 | 51 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant's Response to Plaintiffs' First Set of Requests for Production of Documents (Nos.1-105), (2) Defendant's Answer to Plaintiffs' First Set of Interrogatories (Nos. 1-7), and (3) Defendant's Response to Plaintiffs' First Set of Requests for Production of Things (Nos. 1-3) filed by Hospira, Inc..(Connolly, Arthur) |
| Feb 4, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [47] STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to February 10, 2020 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/4/2020. (fms) |
| Feb 3, 2020 | 47 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit proposed Protective Order to February 10, 2020 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Feb 3, 2020 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Rule 26(a)(1) Initial Disclosures filed by Hospira, Inc..(Connolly, Arthur) |
| Feb 3, 2020 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Teva Pharmaceuticals International GmbH and Cephalon, Inc's Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jan 28, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Jan 28, 2020 | 44 | Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes related to discovery or the protective order. Joinder of Parties due by 1/22/2021. Amended Pleadings due by 1/22/2021. Fact Discovery completed by 3/1/2021. Expert Discovery due by 8/9/2021. Joint Claim Construction Brief due by 10/27/2020. A Markman Hearing is set for 12/15/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 11/10/2021 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 11/15/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/28/2020. (nmf) |
| Jan 28, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before Thursday, February 13, 2020, by email to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, as well as opposing counsel, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. Ordered by Chief Magistrate Judge Mary Pat Thynge on 1/28/20. (cak) |
| Jan 28, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court, having reviewed the case history in light of the January 28, 2020 referral, hereby ORDERS that the procedures for resolving a dispute relating to discovery or the protective order set out in the Scheduling Order, (D.I. 44 at 9-10), will be modified as follows: Should counsel find, after good faith efforts including verbal communication among Delaware and Lead Counsel for all parties to the dispute, that they are unable to resolve a discovery or protective order matter, the parties involved in the dispute shall submit a joint letter with the text set out in the Court's standard Rule 16 Scheduling Order for Patent cases, which can be found in the "Forms" tab of Magistrate Judge Burke's page on the District Court's website. For disputes relating to discovery, the moving party (i.e., the party seeking relief from the Court) should also file a Motion For Teleconference To Resolve Discovery Dispute, and for disputes relating to protective orders, the parties shall file a Joint Motion for Teleconference to Resolve Protective Order Dispute. The suggested text for these motions can be found in the same Forms tab. The Court will thereafter set a discovery or protective order dispute telephone conference. Ordered by Judge Christopher J. Burke on 1/28/2020. (dlb) |
| Jan 24, 2020 | 43 | Proposed Order (18) Docket Text: PROPOSED ORDER (Revised [Proposed] Joint Scheduling Order) by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 23, 2020 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 1/23/2020. (Court Reporter V. Gunning.) Counsel to submit the final revised proposed scheduling order to the Court. (nmf) |
| Jan 21, 2020 | 42 | Main Document (1) Docket Text: Joint Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding Proposed Scheduling Order - re [34] Order Setting Scheduling Conference,. (Attachments: # (1) [Proposed] Scheduling Order)(Hoeschen, Nathan) |
| Jan 21, 2020 | 42 | [Proposed] Scheduling Order (19) |
| Jan 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [41] MOTION for Pro Hac Vice Appearance of Attorney Alex Grabowski filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 1/9/2020. (fms) |
| Jan 9, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alex M. Grabowski for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Jan 9, 2020 | 41 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alex Grabowski - filed by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Jan 7, 2020 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs First Set of Interrogatories to Defendant Hospira, Inc. 2) Plaintiffs First Set of Requests for Production of Documents to Defendant Hospira, Inc. 3) Plaintiffs First Set of Requests for Production of Things to Defendant Hospira, Inc. filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jan 2, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of filer, the certificate of service attached to D.I. [38] has been removed and replaced with a corrected version. (fms) |
| Jan 2, 2020 | 39 | Redacted Document (20) Docket Text: REDACTED VERSION of [38] Answer to Complaint,, Counterclaim, and Affirmative Defenses by Hospira, Inc.. (Connolly, Arthur) |
| Dec 18, 2019 | 37 | Memorandum Opinion (12) Docket Text: REVISED MEMORANDUM OPINION re: [35] SEALED MEMORANDUM OPINION Signed by Judge Colm F. Connolly on 12/18/2019. (nmf) |
| Dec 16, 2019 | 36 | Order on Motion to Dismiss/Failure to State Claim (1) Docket Text: ORDER granting in part and denying in part [13] Motion to Dismiss. Signed by Judge Colm F. Connolly on 12/16/2019. (nmf) |
| Dec 9, 2019 | 34 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 1/23/2020 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 12/9/2019. (nmf) |
| Aug 14, 2019 | 33 | Main Document (2) Docket Text: NOTICE of of Subsequent Authority by Hospira, Inc. re [13] MOTION to Dismiss for Failure to State a Claim (Attachments: # (1) Exhibit A)(Connolly, Arthur) |
| Aug 14, 2019 | 33 | Exhibit A (13) |
| Jun 5, 2019 | 32 | Disclosure Statement (1) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc., Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc.. (Keller, Karen) |
| Feb 28, 2019 | 31 | Notice of Change of Address (1) Docket Text: NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur) |
| Jan 7, 2019 | 30 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel by Hospira, Inc. for Mary I. Akhimien, Esquire (Akhimien, Mary) |
| Nov 26, 2018 | 28 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Mary I. Akhimien regarding Request for Oral Argument on Pending Motion to Dismiss - re [13] MOTION to Dismiss for Failure to State a Claim . (Akhimien, Mary) |
| Nov 26, 2018 | 29 | Redacted Document (15) Docket Text: REDACTED VERSION of [27] Reply Brief in support of Motion to Dismiss Plaintiffs' Complaint by Hospira, Inc.. (Akhimien, Mary) |
| Nov 8, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. Nos. [15] SEALED Exhibits, [20] Redacted Opening Brief, and [21] Redacted Exhibits have been removed and replaced per request of filer. D.I. [15] now includes Ex. 1E and corrects the order of other exhibits. (fms) |
| Nov 2, 2018 | 26 | Redacted Document (30) Docket Text: REDACTED VERSION of [25] Answering Brief in Opposition, by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 17, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [24] STIPULATION TO EXTEND TIME to Submit Briefing re: Hospira's Motion to Dismiss to October 26, 2018 and November 16, 2018 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Set Briefing Schedule: re [13] MOTION to Dismiss for Failure to State a Claim . (Answering Brief due 10/26/2018., Reply Brief due 11/16/2018.). Signed by Judge Colm F. Connolly on 10/17/2018. (fms) |
| Oct 17, 2018 | 24 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Briefing re: Hospira's Motion to Dismiss to October 26, 2018 and November 16, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 12, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] STIPULATION TO EXTEND TIME (and proposed order) to submit Answering Brief and Reply Brief to October 19, 2018 and November 2, 2018 respectively - D.I. 13 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Set Briefing Schedule: re [13] MOTION to Dismiss for Failure to State a Claim . (Answering Brief due 10/19/2018., Reply Brief due 11/2/2018.). Signed by Judge Colm F. Connolly on 10/12/2018. (fms) |
| Oct 12, 2018 | 23 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to submit Answering Brief and Reply Brief to October 19, 2018 and November 2, 2018 respectively - D.I. 13 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Oct 2, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David I. Berl,Ben V. Picozzi,Adam D. Harber,Shaun P. Mahaffy,Elise M. Baumgarten for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, ) |
| Sep 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kenneth G. Schuler for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Sep 27, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Sep 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler filed by Eagle Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 9/26/18. (ntl) |
| Sep 26, 2018 | 22 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler - filed by Eagle Pharmaceuticals, Inc.. (Keller, Karen) |
| Sep 14, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel G. Brown, Marc N. Zubick, and Michelle L. Ernst for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Sep 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown, Michelle L. Ernst, and Marc N. Zubick filed by Eagle Pharmaceuticals, Inc., [19] MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Elise M. Baumgarten, Shaun P. Mahaffy and Ben Picozzi filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, [10] MOTION for Pro Hac Vice Appearance of Attorney Sara T. Horton, Yusuf Esat, and Aaron A. Barlow filed by Hospira, Inc. Signed by Judge Leonard P. Stark on 9/13/18. (ntl) |
| Sep 7, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] STIPULATION TO EXTEND TIME to submit an Answering Brief in Opposition to Defendant Hospira, Inc.'s Motion to Dismiss to October 15, 2018 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 9/7/18. (ntl) |
| Sep 7, 2018 | 19 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber, Elise M. Baumgarten, Shaun P. Mahaffy and Ben Picozzi - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Sep 7, 2018 | 20 | Redacted Document (24) Docket Text: REDACTED VERSION of [14] Opening Brief in Support, by Hospira, Inc.. (Akhimien, Mary) (Main Document 20 replaced on 11/8/2018) (fms). |
| Sep 7, 2018 | 21 | Redacted Document (30) Docket Text: REDACTED VERSION of [15] Exhibit to a Document by Hospira, Inc.. (Akhimien, Mary) (Main Document 21 replaced on 11/8/2018) (fms). |
| Sep 6, 2018 | 18 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit an Answering Brief in Opposition to Defendant Hospira, Inc.'s Motion to Dismiss to October 15, 2018 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Keller, Karen) |
| Sep 5, 2018 | 16 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown, Michelle L. Ernst, and Marc N. Zubick - filed by Eagle Pharmaceuticals, Inc.. (Keller, Karen) |
| Sep 5, 2018 | 17 | Order (1) Docket Text: ORDER re [12] MOTION to Seal 1) Opening Brief in Support of Motion to Dismiss and 2) Exhibits in Support of Motion to Dismiss filed by Hospira, Inc. Signed by Judge Leonard P. Stark on 9/4/18. (ntl) |
| Aug 31, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sara T. Horton, Yusuf Esat, and Aaron A. Barlow - filed by Hospira, Inc.. (Akhimien, Mary) |
| Aug 31, 2018 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Hospira, Inc.. (Akhimien, Mary) |
| Aug 31, 2018 | 12 | Main Document (2) Docket Text: MOTION to Seal 1) Opening Brief in Support of Motion to Dismiss and 2) Exhibits in Support of Motion to Dismiss - filed by Hospira, Inc.. (Attachments: # (1) Text of Proposed Order)(Akhimien, Mary) |
| Aug 31, 2018 | 12 | Text of Proposed Order (1) |
| Aug 31, 2018 | 13 | Main Document (1) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by Hospira, Inc.. (Attachments: # (1) Text of Proposed Order)(Akhimien, Mary) |
| Aug 31, 2018 | 13 | Text of Proposed Order (1) |
| Aug 8, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME to Respond to the Complaint to August 31, 2018 filed by Hospira, Inc. Signed by Judge Leonard P. Stark on 8/8/18. (ntl) |
| Aug 3, 2018 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to August 31, 2018 - filed by Hospira, Inc.. (Connolly, Arthur) |
| Jul 25, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Jul 23, 2018 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.. Hospira, Inc. served on 7/20/2018, answer due 8/10/2018. (Keller, Karen) |
| Jul 20, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hospira, Inc. on 7/20/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
| Jul 19, 2018 | 1 | Main Document (45) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Hospira, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2422906.) - filed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Civil Cover Sheet)(fms) |
| Jul 19, 2018 | 1 | Exhibit A (18) |
| Jul 19, 2018 | 1 | Exhibit B (12) |
| Jul 19, 2018 | 1 | Exhibit C (13) |
| Jul 19, 2018 | 1 | Exhibit D (12) |
| Jul 19, 2018 | 1 | Exhibit E (13) |
| Jul 19, 2018 | 1 | Exhibit F (13) |
| Jul 19, 2018 | 1 | Exhibit G (13) |
| Jul 19, 2018 | 1 | Exhibit H (7) |
| Jul 19, 2018 | 1 | Exhibit I (8) |
| Jul 19, 2018 | 1 | Civil Cover Sheet (2) |
| Jul 19, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Jul 19, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/7/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 12/7/2020. (fms) |
| Jul 19, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): see attached. (fms) |
| Jul 19, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd., Other Affiliate Teva Ltd. for Cephalon, Inc. filed by Cephalon, Inc. (fms) |
| Jul 19, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (fms) |
| Jul 19, 2018 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (fms) |
| Jul 19, 2018 | 1 | Complaint* (1) |
